Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease

This study has been completed.
Information provided by:
La Jolla Pharmaceutical Company Identifier:
First received: May 2, 2002
Last updated: September 22, 2006
Last verified: December 2002
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: December 2002
  Estimated Primary Completion Date: No date given
No publications provided by La Jolla Pharmaceutical Company

Publications automatically indexed to this study by Identifier (NCT Number):